PT909184E - Libertacao de farmaco para um alvo utilizando derivados de sulfonamida - Google Patents
Libertacao de farmaco para um alvo utilizando derivados de sulfonamidaInfo
- Publication number
- PT909184E PT909184E PT97931327T PT97931327T PT909184E PT 909184 E PT909184 E PT 909184E PT 97931327 T PT97931327 T PT 97931327T PT 97931327 T PT97931327 T PT 97931327T PT 909184 E PT909184 E PT 909184E
- Authority
- PT
- Portugal
- Prior art keywords
- glutathione
- sulfonamide
- pharmaco
- liberation
- gsh
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2248996P | 1996-07-03 | 1996-07-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT909184E true PT909184E (pt) | 2004-02-27 |
Family
ID=21809866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97931327T PT909184E (pt) | 1996-07-03 | 1997-07-01 | Libertacao de farmaco para um alvo utilizando derivados de sulfonamida |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0909184B1 (pt) |
| JP (1) | JP2001505533A (pt) |
| AT (1) | ATE249842T1 (pt) |
| AU (1) | AU3498397A (pt) |
| DE (1) | DE69724964T2 (pt) |
| DK (1) | DK0909184T3 (pt) |
| ES (1) | ES2208923T3 (pt) |
| PT (1) | PT909184E (pt) |
| WO (1) | WO1998000173A2 (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6326507B1 (en) | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| AUPQ014699A0 (en) * | 1999-05-04 | 1999-05-27 | Access Pharmaceuticals Australia Pty Limited | Amplification of folate-mediated targeting to tumor cells using nanoparticles |
| US6750199B2 (en) | 2000-07-17 | 2004-06-15 | Micrologix Biotech Inc. | Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| WO2002005837A1 (en) * | 2000-07-17 | 2002-01-24 | Intrabiotics Pharmaceuticals, Inc. | Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| US6511962B1 (en) | 2000-07-17 | 2003-01-28 | Micrologix Biotech Inc. | Derivatives of laspartomycin and preparation and use thereof |
| US6737403B2 (en) | 2000-07-17 | 2004-05-18 | Micrologix Biotech Inc. | Derivatives of laspartomycin and preparation and use thereof |
| US7435755B2 (en) | 2000-11-28 | 2008-10-14 | The Trustees Of Dartmouth College | CDDO-compounds and combination therapies thereof |
| DK1465615T3 (da) | 2002-01-15 | 2012-11-12 | Dartmouth College | Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf |
| US7265096B2 (en) | 2002-11-04 | 2007-09-04 | Xenoport, Inc. | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| DE10347863A1 (de) * | 2003-10-10 | 2005-05-04 | Oxeno Olefinchemie Gmbh | Verfahren zur Herstellung von Benzoesäureestern |
| WO2008064132A2 (en) | 2006-11-17 | 2008-05-29 | Trustees Of Dartmouth College | Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
| US8921340B2 (en) | 2006-11-17 | 2014-12-30 | Trustees Of Dartmouth College | Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions |
| CA2670099A1 (en) | 2006-11-17 | 2008-05-29 | Trustees Of Dartmouth College | Synthesis and biological activities of new tricyclic-bis-enones (tbes) |
| CA2711834C (en) | 2008-01-11 | 2017-03-14 | Reata Pharmaceuticals, Inc. | Synthetic triterpenoids and methods of use in the treatment of disease |
| US7915402B2 (en) | 2008-04-18 | 2011-03-29 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring |
| MX339476B (es) | 2008-04-18 | 2016-05-27 | Reata Pharmaceuticals Inc | Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso. |
| CN104250280A (zh) | 2008-04-18 | 2014-12-31 | 里亚塔医药公司 | 抗氧化剂炎症调节剂:c-17同系化齐墩果酸衍生物 |
| WO2009146216A2 (en) | 2008-04-18 | 2009-12-03 | Reata Pharmaceuticals. Inc. | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| EA019263B1 (ru) | 2008-04-18 | 2014-02-28 | Ритэ Фамэсутикл, Инк. | Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17 |
| EP2833905B1 (en) | 2012-04-04 | 2018-05-02 | Halozyme, Inc. | Combination therapy with hyaluronidase and a tumor-targeted taxane |
| US8921419B2 (en) | 2012-05-08 | 2014-12-30 | Trustees Of Dartmouth College | Triterpenoids and compositions containing the same |
| US20190351031A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
| KR102465333B1 (ko) * | 2019-05-28 | 2022-11-11 | 울산과학기술원 | 글루타치온-ｓ-전이효소 및 표적 세포 또는 표적 단백질 결합능을 갖는 단백질을 포함하는 글루타치온 전구체 약물의 전달체 및 이의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8705477D0 (en) * | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
| FR2645537B1 (fr) * | 1989-04-05 | 1994-03-04 | Fabre Medicament Pierre | Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique |
| HUT64738A (en) * | 1990-06-01 | 1994-02-28 | Du Pont Merck Pharma | Process for preparing 1,4-diamino-2,3-dihydroxi-butane compounds and pharmaceutical compositions contianing them |
| ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| US5882941A (en) * | 1994-05-04 | 1999-03-16 | Massachusette Institute Of Technology | Programmable genotoxic agents and uses therefor |
| IL129871A (en) * | 1994-05-06 | 2003-11-23 | Pharmacia & Upjohn Inc | Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections |
-
1997
- 1997-07-01 WO PCT/US1997/010817 patent/WO1998000173A2/en active IP Right Grant
- 1997-07-01 PT PT97931327T patent/PT909184E/pt unknown
- 1997-07-01 DE DE69724964T patent/DE69724964T2/de not_active Expired - Fee Related
- 1997-07-01 EP EP97931327A patent/EP0909184B1/en not_active Expired - Lifetime
- 1997-07-01 DK DK97931327T patent/DK0909184T3/da active
- 1997-07-01 AU AU34983/97A patent/AU3498397A/en not_active Abandoned
- 1997-07-01 AT AT97931327T patent/ATE249842T1/de not_active IP Right Cessation
- 1997-07-01 JP JP50422098A patent/JP2001505533A/ja not_active Withdrawn
- 1997-07-01 ES ES97931327T patent/ES2208923T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK0909184T3 (da) | 2003-12-22 |
| EP0909184B1 (en) | 2003-09-17 |
| AU3498397A (en) | 1998-01-21 |
| DE69724964T2 (de) | 2004-07-22 |
| WO1998000173A3 (en) | 1998-05-07 |
| EP0909184A2 (en) | 1999-04-21 |
| ATE249842T1 (de) | 2003-10-15 |
| DE69724964D1 (de) | 2003-10-23 |
| JP2001505533A (ja) | 2001-04-24 |
| ES2208923T3 (es) | 2004-06-16 |
| WO1998000173A2 (en) | 1998-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT909184E (pt) | Libertacao de farmaco para um alvo utilizando derivados de sulfonamida | |
| BR0206955A (pt) | Ligantes de receptores de canabinóides | |
| DE60207831D1 (de) | Thiol-modifizierte hyaluronan-derivate | |
| ES2181055T3 (es) | Formulaciones galenicas que contienen antagonistas de opiaceos. | |
| BG106569A (en) | Purine derivatives | |
| SV1999000251A (es) | Derivados de 3,3-biarilpiperidina y 2,2-biarilmorfolina ref. pcl0085/82805/bb | |
| DE60330356D1 (en) | Stickstoff-lost-derivaten | |
| TR200001906T2 (tr) | Koks-Inhibitörleri olarak 2,3-ikameli indol bileşikleri. | |
| IL123776A0 (en) | Novel derivatives of cyclodepsipeptide PF 1022 | |
| IL134894A (en) | 2-substituted-1,3,4,5-tetrahydro-2h-gamma-carbolines, their preparation and pharmaceutical compositions containing them | |
| BR0308071A (pt) | Inibidores da protéina farnesil transferase como agentes antitumores | |
| MY133512A (en) | Non-steroidal il-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors | |
| BR0104358A (pt) | Formulações de taxana tendo solubilidade aperfeiçoada | |
| BR0311642A (pt) | Formulação de divalproex de sódio de liberação aumentada | |
| ES2134313T3 (es) | Utilizacion de derivados de pregnano para el tratamiento de tumores. | |
| ATE266029T1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
| AU5879798A (en) | Agents inhibiting progress of pterygium and postoperative recurrence of the same | |
| NZ510938A (en) | Phospholipid derivatives of non-steroidal anti-inflammatory drugs | |
| BR0110871A (pt) | Derivados de sulfonamida | |
| DK1142905T3 (da) | Hidtil ukendt depsipeptidforbindelse | |
| BR9917315A (pt) | Composições medicinais para liberação imediata para uso oral | |
| AU5343798A (en) | Indolomorphinan derivative and agent for curing and preventing cerebral disorder | |
| BR0110874A (pt) | Derivados de sulfonamida | |
| AU2001260419A1 (en) | Use of n,n'-dibenzyl ethylene diamine n,n'-diacetic acid derivatives as anti-pollution agent | |
| PA8450901A1 (es) | Derivados de eritromicina |